A risk model for first cycle febrile neutropenia in cancer patients receiving systemic chemotherapy
Publication
, Conference
Lyman, GH; Crawford, J; Wolff, DA; Culakova, E; Poniewierski, MS; Dale, DC
Published in: JOURNAL OF CLINICAL ONCOLOGY
2005
Duke Scholars
Published In
JOURNAL OF CLINICAL ONCOLOGY
EISSN
1527-7755
ISSN
0732-183X
Publication Date
2005
Volume
23
Issue
16
Start / End Page
759S / 759S
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Lyman, G. H., Crawford, J., Wolff, D. A., Culakova, E., Poniewierski, M. S., & Dale, D. C. (2005). A risk model for first cycle febrile neutropenia in cancer patients receiving systemic chemotherapy. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 23, pp. 759S-759S).
Lyman, G. H., J. Crawford, D. A. Wolff, E. Culakova, M. S. Poniewierski, and D. C. Dale. “A risk model for first cycle febrile neutropenia in cancer patients receiving systemic chemotherapy.” In JOURNAL OF CLINICAL ONCOLOGY, 23:759S-759S, 2005.
Lyman GH, Crawford J, Wolff DA, Culakova E, Poniewierski MS, Dale DC. A risk model for first cycle febrile neutropenia in cancer patients receiving systemic chemotherapy. In: JOURNAL OF CLINICAL ONCOLOGY. 2005. p. 759S-759S.
Lyman, G. H., et al. “A risk model for first cycle febrile neutropenia in cancer patients receiving systemic chemotherapy.” JOURNAL OF CLINICAL ONCOLOGY, vol. 23, no. 16, 2005, pp. 759S-759S.
Lyman GH, Crawford J, Wolff DA, Culakova E, Poniewierski MS, Dale DC. A risk model for first cycle febrile neutropenia in cancer patients receiving systemic chemotherapy. JOURNAL OF CLINICAL ONCOLOGY. 2005. p. 759S-759S.
Published In
JOURNAL OF CLINICAL ONCOLOGY
EISSN
1527-7755
ISSN
0732-183X
Publication Date
2005
Volume
23
Issue
16
Start / End Page
759S / 759S
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences